Gene Therapy for X-linked Severe Combined Immunodeficiency
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:September 28, 2021Completed
Hide Studies Not Open or Pending
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:September 28, 2021Completed
Condition(s):X-linked Severe Combined Immunodeficiency (XSCID)Last Updated:March 17, 2023Suspended
Condition(s):X-linked Severe Combined ImmunodeficiencyLast Updated:August 1, 2017Unknown status
Condition(s):X-Linked Combined Immunodeficiency DiseasesLast Updated:December 4, 2019Unknown status
Condition(s):Growth Failure; X-linked Severe Combined Immunodeficiency (XSCID); Growth Hormone ResistenceLast Updated:July 3, 2015Terminated
Condition(s):Severe Combined Immunodeficiency, X-LinkedLast Updated:March 16, 2022Recruiting
Condition(s):Gene TherapyLast Updated:March 27, 2020Recruiting
Condition(s):Severe Combined Immunodeficiency Disease, X-linkedLast Updated:January 10, 2023Recruiting
Condition(s):SCID, X LinkedLast Updated:September 19, 2019Unknown status
Condition(s):Severe Combined ImmunodeficiencyLast Updated:July 2, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.